Therapeutic Asset Ratings

13,248 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
(+)-VINCRISTINE Esophagogastric Cancer	AbbVie	P1	CCC (52)
VINCRISTINE SULFATE MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome	Prelude Therapeutics	P1	CCC (52)
VINCRISTINE SULFATE Myelodysplastic Syndrome (MDS)	Prelude Therapeutics	P1	CCC (52)
Vinorelbine Solid Neoplasm	National Cancer Institute (NCI)	P1	CCC (52)
Cediranib Gastric Cancer	National Cancer Institute (NCI)	P1	CCC (51)
Entinostat Invasive Breast Carcinoma	UNC Lineberger Comprehensive Cancer Center	P1	CCC (51)
Epirubicin Myelodysplastic Syndrome	City of Hope Medical Center	P1	CCC (51)
Omeprazole Advanced Solid Tumor	Genentech, Inc.	P1	CCC (51)
Pembrolizumab Myelodysplastic Syndrome	City of Hope Medical Center	P1	CCC (51)
RIFALDAZINE Advanced Solid Tumors	Jiangsu HengRui Medicine Co., Ltd.	P1	CCC (51)
Rosuvastatin Obesity	Beijing QL Biopharmaceutical Co.,Ltd	P1	CCC (51)
Senaparib Solid Tumor	Impact Therapeutics, Inc.	P1	CCC (51)
Vorinostat Adult Mixed Glioma	National Cancer Institute (NCI)	P1	CCC (51)
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A Lung Non-Small Cell Carcinoma	Roswell Park Cancer Institute	P1	CCC (50)
5-azacytidine Advanced Solid Tumor Malignancies	Mohammed Milhem	P1	CCC (50)
[68ga]ga-nota-exendin-4 Insulinoma	Peking Union Medical College Hospital	P1	CCC (50)
Belinostat Recurrent Grade 1 Follicular Lymphoma	National Cancer Institute (NCI)	P1	CCC (50)
Budigalimab Advanced Solid Tumors Cancer	AbbVie	P1	CCC (50)
Capecitabine Advanced Sarcoma	OHSU Knight Cancer Institute	P1	CCC (50)
cd22 car-t B-cell Lymphoma Recurrent	Rong Tao	P1	CCC (50)
cd22 car-t B-cell Lymphoma Refractory	Rong Tao	P1	CCC (50)
cd5-targeted car-t cells T-Acute Lymphoblastic Leukemia	Zhejiang University	P1	CCC (50)
Cobimetinib Recurrent Acute Myeloid Leukemia	City of Hope Medical Center	P1	CCC (50)
Cyclophosphamide Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)	Tongji Hospital	P1	CCC (50)
Cyclophosphamide Autoimmune Diseases of the Nervous System	Indapta Therapeutics, INC.	P1	CCC (50)

Showing 101 to 125 of 13,248 assets

PreviousPage 5 of 530Next